Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Tsumura &
Acquired Company
Yomeishu Seizo
Description
Tsumura & Co. has successfully acquired Yomeishu Seizo for JPY 6.8 billion, finalizing the deal on September 1, 2026. The acquisition aims to boost Tsumura's healthcare portfolio, integrating Yomeishu's products into Tsumura's operations. The financial effects of this acquisition will begin to reflect in Tsumura's consolidated results from Q2 of fiscal year 2027. This strategic move is designed to enhance Tsumura's growth in the healthcare market.
Fundz sees it the moment Tsumura & makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Yomeishu Seizo?
Yomeishu Seizo was acquired by Tsumura &, based in Tokyo. The deal was reported on October 7, 2026. Tsumura & Co. operates in the pharmaceutical industry, focusing on the production and wholesale of traditional Chinese medicine. Tsumura & is privately held and operates in Biotechnology.
When did Tsumura & acquire Yomeishu Seizo?
Tsumura &'s acquisition of Yomeishu Seizo was reported on October 7, 2026. Tsumura & Co. has successfully acquired Yomeishu Seizo for JPY 6.8 billion, finalizing the deal on September 1, 2026. The acquisition aims to boost Tsumura's healthcare portfolio, integrating Yomeishu's products into Tsumura's operations. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Yomeishu Seizo do?
Yomeishu Seizo is a company involved in the production of health beverages under the traditional Japanese medicinal philosophies. It focuses on research and development to create products that promote wellness and health. It is privately held, operating in Health Care, and is based in Japan.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.